Precision medicine in acute lymphoblastic leukemia: A narrative review of current strategies and future directions
Acute lymphoblastic leukemia (ALL) is a genetically heterogeneous hematologic malignancy and the most common cancer in children, with significant morbidity and mortality in adults. Advances in molecular diagnostics and targeted therapies have shifted treatment from uniform chemotherapy toward precision medicine approac...